Revenue climbed to 69.51 billion yen, up from 63.51 billion yen during the prior period. This top-line expansion fueled a broader improvement in profitability, with operating profit surging to 979 million yen compared to 293 million yen a year earlier. Pretax profit followed a similar trajectory, reaching 715 million yen from 136 million yen.
In section Market Quotes
Pharmarise Holdings Swings to Profit on Revenue Growth
A 114 million yen net profit marks a sharp reversal for Pharmarise Holdings Corp., which ended its fiscal year on May 31 with a significant recovery from the previous year’s 367 million yen loss. The Tokyo-listed company successfully leveraged rising revenues to pull its bottom line back into positive territory.
Shareholders saw earnings of 10.01 yen per share, a stark contrast to the 32.48 yen loss per share recorded in 2025. Diluted earnings per share were reported at 9.62 yen. These results, compiled under Japanese accounting standards, reflect a period of stabilization for the firm as it moves past the deficits that hindered its recent financial performance.
Comments (0)
No comments yet. Be the first!